Menora Mivtachim Holdings Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$140M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$73.8M |
| 3 |
Sony
SONY
|
+$56.6M |
| 4 |
Apple
AAPL
|
+$44.9M |
| 5 |
JPMorgan Chase
JPM
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$53.6M |
| 2 |
Regions Financial
RF
|
+$50.2M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$47.4M |
| 4 |
Viatris
VTRS
|
+$36M |
| 5 |
KeyCorp
KEY
|
+$33.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.13% |
| 2 | Technology | 19.24% |
| 3 | Financials | 16.85% |
| 4 | Industrials | 9.09% |
| 5 | Communication Services | 8.61% |
Similar funds
Menora Mivtachim Holdings's Q4 2018 Portfolio in Review
As of Q4 2018, Menora Mivtachim Holdings held 97 positions worth $3.46B, down 6.3% from $3.69B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Menora Mivtachim Holdings deployed $324M of net new capital in Q4 2018, opening 4 new positions and adding to 31 existing holdings. Its largest new stake was Delek US: 3,696,670 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Mellanox Technologies, Ltd., an estimated $47.4M trimmed.
- Menora Mivtachim Holdings's largest Q4 2018 buy was Delek US: 3,696,670 shares worth $120M.
- Menora Mivtachim Holdings added most to Teva Pharmaceuticals in Q4 2018, an estimated $73.8M increase.
- Menora Mivtachim Holdings's biggest Q4 2018 reduction was Mellanox Technologies, Ltd., cutting an estimated $47.4M.
- Menora Mivtachim Holdings fully exited Goldman Sachs in Q4 2018, selling an estimated $53.6M.
- Menora Mivtachim Holdings's ten largest holdings make up 29% of its $3.46B portfolio in Q4 2018.
- Menora Mivtachim Holdings opened 4 new positions and closed 12 in Q4 2018.
- Menora Mivtachim Holdings's portfolio value fell 6.3% quarter-over-quarter to $3.46B.
Based on Menora Mivtachim Holdings's 13F filing for Q4 2018, filed 7 Feb 2019.